Actavis, Sandoz Open Fire On Prandin Patent
Actavis Pharma Manufacturing Pvt. Ltd. LLC and Sandoz Inc. have fired back at Novo Nordisk Inc.'s bid to block them from producing generic versions of diabetes treatment Prandin, alleging that Novo...To view the full article, register now.
Already a subscriber? Click here to view full article